Estelle S. Harris

Intensive Care Medicine
50 N Medical Dr
Salt Lake City, UT 84132

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19.

Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19.

Journal: Critical care explorations
Published: June 22, 2026

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

Journal: Chest
Published: March 25, 2026

Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025.

Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025.

Journal: medRxiv : the preprint server for health sciences
Published: February 09, 2026

Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19.

Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19.

Journal: JAMA network open
Published: February 03, 2026

Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial.

Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial.

Journal: CHEST critical care
Published: January 23, 2026

Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023.

Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023.

Journal: Emerging infectious diseases
Published: January 22, 2026

Genomic surveillance of human metapneumovirus in the United States, 2010-2025.

Genomic surveillance of human metapneumovirus in the United States, 2010-2025.

Journal: The Journal of infectious diseases
Published: January 18, 2026

Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024.

Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024.

Journal: Vaccine
Published: September 17, 2025

Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.

Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.

Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.

Journal: JAMA
Published: August 30, 2025

Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023-2024.

Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023-2024.

Journal: Vaccine
Published: July 21, 2025

Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 03, 2025
Showing 1-12 of 43

Last Updated: 09/26/2026